Targeted-protein Degradation Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Targeted-protein Degradation Therapeutics Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Targeted proteolysis (TPD) has emerged as a new and innovative chemical tool and therapeutic modality. By selecting a proteolytic pathway, TPD promotes the complete clearance of protein molecules inside or outside the cell. While pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular adhesives are intercepting the ubiquitin-proteasome system, novel modalities employ autophagy or endo-lysosomal pathways.

Market Segments

By Types

• ARV-110
• ARV-471
• Other

By Applications

• Cancer
• Neuroscience
• Other

Key Players

• Arvinas
• Nurix Therapeutics
• Kymera Therapeutics
• C4 Therapeutics

Scope of the Report

The research study analyzes the global Targeted-protein Degradation Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Targeted-protein Degradation Therapeutics Market Report

1. What was the Targeted-protein Degradation Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Targeted-protein Degradation Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Targeted-protein Degradation Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.